Related Experiment Video
Updated: Jan 15, 2026
09:17
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
18.7K
[Metastasis and hypoxia-inducible factor].
Masanobu Kobayashi1, Koji Nakagawa
1School of Nursing and Services, Health Science University of Hokkaido, Hokkaido, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 19, 2010
Summary
Hypoxia-inducible factors (HIFs) drive cancer cell adaptation to low oxygen, promoting metastasis. This review explores how fluctuating hypoxia impacts HIFs and metastasis-associated genes.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Physiology
Context:
- Cancer cells adapt to hypoxic environments via anaerobic metabolism and angiogenesis.
- Hypoxia-inducible factors (HIFs), comprising HIF-1beta and oxygen-regulated HIF-1alpha/2alpha/3alpha subunits, mediate these adaptive responses.
- Altered gene expression driven by HIFs in response to tumor hypoxia is linked to increased metastatic potential.
Purpose:
- To review hypoxia-responsive genes implicated in cancer metastasis.
- To explore the under-addressed effects of fluctuating hypoxia on HIF-mediated gene expression.
- To connect HIF activity in varying hypoxic conditions to cancer cell metastatic efficiency.
Summary:
- Hypoxia-inducible factors (HIFs) stabilize in low oxygen, regulating target genes involved in cancer cell adaptation and metastasis.
- While diffusion-limited hypoxia is established, fluctuating (perfusion-limited) hypoxia's role in HIF-driven gene expression and metastasis requires further investigation.
- This review focuses on hypoxia-responsive genes critical to the metastatic process.
Impact:
- Highlights the role of HIFs in cancer progression and metastasis under hypoxic conditions.
- Emphasizes the need to study fluctuating hypoxia's impact on cancer biology.
- Provides a foundation for understanding HIF-mediated gene regulation in diverse tumor microenvironments.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
02:30Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
01:23Hypoxia
1.9K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.9K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K